Somatotroph Tumors and the Epigenetic Status of the


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
15 Jul 2021
Historique:
received: 03 06 2021
revised: 09 07 2021
accepted: 10 07 2021
entrez: 24 7 2021
pubmed: 25 7 2021
medline: 20 8 2021
Statut: epublish

Résumé

Forty percent of somatotroph tumors harbor recurrent activating

Identifiants

pubmed: 34299200
pii: ijms22147570
doi: 10.3390/ijms22147570
pmc: PMC8306130
pii:
doi:

Substances chimiques

Chromogranins 0
GNAS protein, human EC 3.6.1.-
GTP-Binding Protein alpha Subunits, Gs EC 3.6.5.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Groupement de Recherche CREST-NET
ID : GDR2031
Organisme : Excellence Initiative of Aix Marseille University -A*Midex- a French "Investissement d'Avenir"
ID : NA
Organisme : Institut National de lutte contre le Cancer (INCa)
ID : NA
Organisme : MarMaRa Institute
ID : NA
Organisme : French Ministry of Health
ID : NA

Références

Endocrinology. 2007 Jun;148(6):2973-83
pubmed: 17363453
Mol Cell Biol. 2000 Aug;20(16):5808-17
pubmed: 10913164
Neuroendocrinology. 2006;83(3-4):230-9
pubmed: 17047388
Front Endocrinol (Lausanne). 2021 Feb 23;11:614981
pubmed: 33708174
J Clin Invest. 2001 Mar;107(6):R31-6
pubmed: 11254676
Hum Mol Genet. 2003 May 15;12(10):1121-30
pubmed: 12719376
Cancer Cell. 2020 Jan 13;37(1):123-134.e5
pubmed: 31883967
Endocrinology. 2011 Apr;152(4):1234-43
pubmed: 21285319
Endocr Relat Cancer. 2009 Sep;16(3):1029-43
pubmed: 19556287
Exp Biol Med (Maywood). 2003 Oct;228(9):1004-17
pubmed: 14530508
Endocr Relat Cancer. 2013 Sep 16;20(5):753-66
pubmed: 23940012
J Clin Endocrinol Metab. 1999 Aug;84(8):2759-65
pubmed: 10443675
J Clin Invest. 2000 Nov;106(9):1167-74
pubmed: 11067869
Pediatrics. 2015 Apr;135(4):e1079-83
pubmed: 25802348
Oncogene. 2015 Feb 26;34(9):1174-84
pubmed: 24662816
J Clin Endocrinol Metab. 2002 Oct;87(10):4736-40
pubmed: 12364467
J Clin Endocrinol Metab. 1998 Dec;83(12):4386-90
pubmed: 9851782
Endocr Relat Cancer. 2013 Jun 27;20(4):495-505
pubmed: 23702468
Science. 1990 Aug 10;249(4969):655-9
pubmed: 2116665
Int J Cancer. 2007 Sep 15;121(6):1245-52
pubmed: 17514647
Proc Natl Acad Sci U S A. 2005 Apr 12;102(15):5513-8
pubmed: 15811946
Nat Genet. 2004 Aug;36(8):894-9
pubmed: 15273687
Eur J Endocrinol. 2016 Mar;174(3):363-72
pubmed: 26701869
J Clin Endocrinol Metab. 2008 Apr;93(4):1203-10
pubmed: 18198230
J Clin Endocrinol Metab. 2003 Sep;88(9):4336-41
pubmed: 12970307
Nature. 1989 Aug 31;340(6236):692-6
pubmed: 2549426
Endocr Pathol. 2017 Dec;28(4):302-307
pubmed: 27838885
J Neuroendocrinol. 2009 Nov;21(11):869-77
pubmed: 19732293
Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):10038-43
pubmed: 9707596

Auteurs

Pauline Romanet (P)

Aix Marseille Univ, INSERM, APHM, MMG, UMR1251, Marmara Institute, La Conception, Hospital Laboratory of Molecular Biology, 13385 Marseille, France.

Justine Galluso (J)

Aix Marseille Univ, INSERM, APHM, MMG, UMR1251, Marmara Institute, La Conception, Hospital Laboratory of Molecular Biology, 13385 Marseille, France.

Peter Kamenicky (P)

Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d'Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l'Hypophyse, 94270 Le Kremlin-Bicêtre, Île-de-France, France.

Mirella Hage (M)

Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d'Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l'Hypophyse, 94270 Le Kremlin-Bicêtre, Île-de-France, France.

Marily Theodoropoulou (M)

Medizinische Klinik und Poliklinik IV, LMU Klinikum, Ludwig Maximilian University Munich, 80336 Munich, Germany.

Catherine Roche (C)

APHM, La Conception Hospital, Laboratory of Molecular Biology, 13385 Marseille, France.

Thomas Graillon (T)

Aix Marseille Univ, INSERM, APHM, MMG, UMR1251, Marmara Institute, La Timone Hospital Department of Neurosurgery, 13385 Marseille, France.

Heather C Etchevers (HC)

Aix Marseille Univ, INSERM, MMG, UMR1251, Marmara Institute, 13385 Marseille, France.

Daniel De Murat (D)

Université de Paris, Institut Cochin, Inserm U1016, CNRS UMR8104, F-75014 Paris, France.

Grégory Mougel (G)

Aix Marseille Univ, INSERM, APHM, MMG, UMR1251, Marmara Institute, La Conception, Hospital Laboratory of Molecular Biology, 13385 Marseille, France.

Dominique Figarella-Branger (D)

Aix-Marseille Univ, APHM, CNRS, INP, Inst Neurophysiopathol, CHU Timone, Service d'Anatomie Pathologique et de Neuropathologie, 13385 Marseille, France.

Henry Dufour (H)

Aix Marseille Univ, INSERM, APHM, MMG, UMR1251, Marmara Institute, La Timone Hospital Department of Neurosurgery, 13385 Marseille, France.

Thomas Cuny (T)

Aix Marseille Univ, INSERM, APHM, MMG, UMR1251, Marmara Institute, Department of Endocrinology, Hospital La Conception, 13385 Marseille, France.

Guillaume Assié (G)

Université de Paris, Institut Cochin, Inserm U1016, CNRS UMR8104, F-75014 Paris, France.
Department of Endocrinology, Center for Rare Adrenal Diseases, Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, 75014 Paris, France.

Anne Barlier (A)

Aix Marseille Univ, INSERM, APHM, MMG, UMR1251, Marmara Institute, La Conception, Hospital Laboratory of Molecular Biology, 13385 Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH